[HTML][HTML] Pathogenesis of venous thromboembolism: when the cup runneth over

G Lippi, M Franchini - Seminars in thrombosis and hemostasis, 2008 - thieme-connect.com
ABSTRACT A comprehensive understanding of the pathogenesis of venous thrombosis is
essential for identifying patients at increased risk and who may therefore benefit from more …

Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening

MG Andreassi, N Botto, S Maffei - Clinical Chemistry and Laboratory …, 2006 - degruyter.com
Venous thromboembolism is a well-known complication of oral contraception and hormonal
replacement therapy. Inherited thrombophilia is viewed as an important determinant in …

Comparison of the impact of four generations of progestins on hemostatic variables

S Oslakovic, R Zadro - Clinical and applied thrombosis …, 2014 - journals.sagepub.com
This study was undertaken to evaluate the impact of progestins as part of low-estrogen
(ethinyl estradiol [EE2]≤ 35 μg) combined oral contraceptives (COCs) on hemostatic …

A review of transdermal hormonal contraception: focus on the ethinylestradiol/norelgestromin contraceptive patch

A Graziottin - Treatments in Endocrinology, 2006 - Springer
Imperfect use of contraceptive methods notably increases the likelihood of pregnancy. One
means of improving user adherence with hormonal contraception is to minimize the dosing …

Effect of two low-dose gestodene containing monophasic oral contraceptives on hemostasis in Bulgarian women

E Uchikova, B Pehlivanov - Expert Opinion on Pharmacotherapy, 2008 - Taylor & Francis
Objective: To compare the effects of two monophasic oral contraceptives upon coagulation,
fibrinolysis and the system of natural inhibitors (anticoagulant pathways) in Bulgarian …

Hemorheological mechanisms for increased thrombosis in subjects using gestodene

AC Swanepoel, HC Roberts, P Soma… - Microscopy …, 2018 - Wiley Online Library
There are several possible mechanisms by which combined oral contraceptives (COC) use
increase venous thromboembolism (VTE) risk. Melodene® is a monophasic COC containing …

[PDF][PDF] S‹ GARA VE ORAL KONTRASEPT‹ F KULLANIMININ PROTE‹ NC, PROTE‹ NS ve ANT‹ TROMB‹ N III DÜZEYLER‹ NE ETK‹ S‹

B Tunç - acarindex.com
Objective: To investigate the effects of low-dose oral contraceptive usage among smoking
and nonsmoking women on some blood coagulation factors. Instution: Süleyman Demirel …

Characterization of a protein S assay measuring the APC cofactor activity/Charakterisierung eines APC-Kofaktor basierten Protein S-Aktivitätstests

J Patzke, M Merz, A Siegemund - LaboratoriumsMedizin, 2007 - degruyter.com
Zusammenfassung Der Aktivitätstest Protein S Ac basiert auf der Rolle von Protein S als
Kofaktor für aktiviertes Protein C (APC). Zur Bestimmung der Leistungsmerkmale wurden …

Utjecaj oralne kontracepcije na čimbenike zgrušavanja i fibrinolize

S Oslaković - 2014 - repozitorij.pharma.unizg.hr
Sažetak Oralni kontraceptivi imaju brojne učinke na organizam žene poput poželjnog
smanjenja pojavnosti zloćudnih bolesti jajnika i endometrija, ali i nepoželjne učinke od kojih …

[PDF][PDF] Routine tests of haemostasis and low-oestrogen oral contraceptives: what to expect?

R Zadro, S Oslakovic - Clin. Lab, 2014 - researchgate.net
Background: Frequent requests from gynaecologists for testing of haemostatic parameters in
women using hor-monal contraception in order to predict development of thromboembolic …